JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabriëls, G.
Right arrow Articles by Greven, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabriëls, G.
Right arrow Articles by Greven, J.

Vol. 290, Issue 2, 710-715, August 1999

Evidence for Differential Regulation of Renal Proximal Tubular p-Aminohippurate and Sodium-Dependent Dicarboxylate Transport1

G. Gabriëls, A. Werners, S. Mauss and J. Greven

Department of Pharmacology and Toxicology, Rheinisch Westfälische Technische Hochschule Aachen, Aachen, Germany

In renal proximal tubules, the basolateral organic anion [p-aminohippurate (PAH)] transporter is functionally coupled to the sodium-dependent dicarboxylate transporter. This study was undertaken to elucidate whether protein kinases differentially modulate the activities of these transporters. In isolated S2 segments of proximal tubules microdissected from rabbit kidneys, we investigated whether the transporters are regulated by tyrosine kinases, phosphatidylinositol 3-kinase (PI3K), and mitogen-activated protein kinase (MAPK). The tubules were collapsed; hence, tubular uptake of the marker substances [3H]PAH and [14C]glutarate reflects transport across the basolateral cell membrane. Genistein, a selective inhibitor of tyrosine kinase, diminished PAH uptake at 10-7 M by 15.6 ± 11.7% and at 10-6 M by 25.6 ± 9.1%. An inactive analog of genistein, diadzein, was without effect even at a concentration 100-fold higher than the lowest concentration of genistein, which produced significant reduction of PAH uptake. At 10-7 M, wortmannin, a selective inhibitor of PI3K, reduced PAH uptake by 24.1 ± 11.3% and, at 10-6 M, it reduced it by 32.9 ± 11.8%. The selective inhibitor of MAPK, PD98059, diminished PAH uptake at 5 × 10-5 M by 23.2 ± 6.8% and at 10-4 M by 18.3 ± 5.2%. Glutarate uptake was not reduced by any of these protein kinase inhibitors. Insulin had no effect on PAH uptake. These findings indicate that, in addition to protein kinase A, protein kinase C and calcium/calmodulin-dependent protein kinase II (former studies from this laboratory), as well as tyrosine kinases, PI3K, and MAPK, modulate renal basolateral PAH transport, whereas none of these protein kinases affects basolateral glutarate transport. Thus, the results provide evidence for differential regulation of basolateral transporters for PAH and dicarboxylates.


0022-3565/99/2902-0710$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Soodvilai, S. H. Wright, W. H. Dantzler, and V. Chatsudthipong
Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1057 - F1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Soodvilai, V. Chatsudthipong, K. K. Evans, S. H. Wright, and W. H. Dantzler
Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules
Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1021 - F1029.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. H. Wright and W. H. Dantzler
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Physiol Rev, July 1, 2004; 84(3): 987 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Sauvant, D. Hesse, H. Holzinger, K. K. Evans, W. H. Dantzler, and M. Gekle
Action of EGF and PGE2 on basolateral organic anion uptake in rabbit proximal renal tubules and hOAT1 expressed in human kidney epithelial cells
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F774 - F783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Cetinkaya, G. Ciarimboli, G. Yalcinkaya, T. Mehrens, A. Velic, J. R. Hirsch, V. Gorboulev, H. Koepsell, and E. Schlatter
Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F293 - F302.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Sauvant, H. Holzinger, and M. Gekle
Short-Term Regulation of Basolateral Organic Anion Uptake in Proximal Tubular OK cells: EGF Acts via MAPK, PLA2, and COX1
J. Am. Soc. Nephrol., August 1, 2002; 13(8): 1981 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Soares-Da-Silva and M. P. Serrao
Molecular modulation of inward and outward apical transporters of L-dopa in LLC-PK1 cells
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F736 - F746.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Sauvant, H. Holzinger, and M. Gekle
Modulation of the Basolateral and Apical Step of Transepithelial Organic Anion Secretion in Proximal Tubular Opossum Kidney Cells. ACUTE EFFECTS OF EPIDERMAL GROWTH FACTOR AND MITOGEN-ACTIVATED PROTEIN KINASE
J. Biol. Chem., April 27, 2001; 276(18): 14695 - 14703.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.